South Australia
Mutual Recognition (South Australia) Regulations 2013
under the Mutual Recognition (South Australia) Act 1993

Contents
1	Short title
2	Commencement
3	Interpretation
4	Temporary exemptions—synthetic drugs
Schedule 1—Revocation of Mutual Recognition (South Australia) (Temporary Exemptions) Regulations 1999
1	Revocation of regulations

1—Short title
These regulations may be cited as the Mutual Recognition (South Australia) Regulations 2013.
2—Commencement
These regulations come into operation on the day on which they are made.
3—Interpretation
In these regulations—
Act means the Mutual Recognition (South Australia) Act 1993.
4—Temporary exemptions—synthetic drugs
	(1)	For the purposes of section 5 of the Act and section 15 of the Commonwealth Act, the substances specified in subregulation (4) are declared to be goods to which section 15 of the Commonwealth Act applies.
	(2)	For the purposes of section 5 of the Act and section 15 of the Commonwealth Act, the provisions of the Controlled Substances (Controlled Drugs, Precursors and Plants) Regulations 2000 inserted by the Controlled Substances (Controlled Drugs, Precursors and Plants) (Synthetic Controlled Drugs) Variation Regulations 2013 are declared to be a law to which section 15 of the Commonwealth Act applies.
	(3)	The exemptions from the Commonwealth Act under this regulation have effect for a period of 12 months following the commencement of this regulation.
	(4)	The following substances and any preparation containing 1 or more of the following substances are specified for the purposes of subregulation (1):
	(a)	5-(2-aminopropyl)benzofuran (‘5-APB’);
	(b)	6-(2-aminopropyl)benzofuran (‘6-APB’);
	(c)	(RS)-2-ethylamino-1-(4-methylphenyl)propan-1-one (‘4-methylethcathinone’ or ‘4‑MEC’);
	(d)	1-phenyl-2-(methylamino)pentan-1-one (‘pentedrone’);
	(e)	(RS)-1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (‘alpha-PVP’ or ‘alpha‑pyrrolidinovalerophenone');
	(f)	1-(thiophen-2-yl)-2-methylaminopropane (‘methiopropamine’);
	(g)	2-(3-Methoxyphenyl)-2-(ethylamino)cyclohexanone (‘methoxetamine’);
	(h)	arylcyclohexylamines;
	(i)	2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (‘25B‑NBOMe’);
	(j)	2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (‘25C‑NBOMe’);
	(k)	2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (‘25I‑NBOMe’);
	(l)	1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide (‘APINACA’ or ‘AKB48’);
	(m)	(1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (‘XLR‑11’);
	(n)	(1-pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone (‘UR‑144’);
	(o)	4-Hydroxybutanoic acid lactone (‘GBL’).

Schedule 1—Revocation of Mutual Recognition (South Australia) (Temporary Exemptions) Regulations 1999
1—Revocation of regulations
The Mutual Recognition (South Australia) (Temporary Exemptions) Regulations 1999 are revoked.
Note—
As required by section 10AA(2) of the Subordinate Legislation Act 1978, the Minister has certified that, in the Minister's opinion, it is necessary or appropriate that these regulations come into operation as set out in these regulations.
Made by the Governor
with the advice and consent of the Executive Council
on 19 September 2013
No 234 of 2013
AGO0107/13CS